Provides for Medicaid transparency. (8/1/13) (EN NO IMPACT See Note)
Requests DHH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medications by persons enrolled in Medicaid managed care
Provides for certain "transparency" reporting to the legislature by the Department of Health and Hospitals concerning the Louisiana Medicaid Bayou Health program and the Louisiana Behavioral Health Partnership and Coordinated System of Care programs. (8/1/12)
Requests DHH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medication by persons enrolled in Medicaid managed care.
Provides for reporting measures for the Medicaid managed care program and the Louisiana Behavioral Health Partnership program. (gov sig) (RE NO IMPACT See Note)
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Provides for cost containment, cost sharing, and long term services and supports in the Medicaid managed care program (OR SEE FISC NOTE GF EX)
Relating to the operation and administration of Medicaid, including the Medicaid managed care program.
Relating to the operation and administration of Medicaid, including the Medicaid managed care program.